Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M R Wright

Showing results (111-120 of 113) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 113 results.
The New England Journal of Medicine|May 23, 2019
Nasal High-Flow Therapy for Newborn Infants in Special Care NurseriesBrett J Manley, Gaston R B Arnolda, Ian M R Wright, et al.
Chemistry & Biology|November 18, 1998
Design and selection of DMP 850 and DMP 851: the next generation of cyclic urea HIV protease inhibitorsJ D Rodgers, P Y Lam, B L Johnson, et al.
Journal of Medicinal Chemistry|February 15, 2001
Discovery of 1-[3-(aminomethyl)phenyl]-N-3-fluoro-2'-(methylsulfonyl)-[1,1'-biphenyl]-4-yl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide (DPC423), a highly potent, selective, and orally bioavailable inhibitor of blood coagulation factor XaD J Pinto, M J Orwat, S Wang, et al.
Pageof 12

Showing results (111-120 of 113) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 113 results.
The New England Journal of Medicine|May 23, 2019
Nasal High-Flow Therapy for Newborn Infants in Special Care NurseriesBrett J Manley, Gaston R B Arnolda, Ian M R Wright, et al.
Chemistry & Biology|November 18, 1998
Design and selection of DMP 850 and DMP 851: the next generation of cyclic urea HIV protease inhibitorsJ D Rodgers, P Y Lam, B L Johnson, et al.
Journal of Medicinal Chemistry|February 15, 2001
Discovery of 1-[3-(aminomethyl)phenyl]-N-3-fluoro-2'-(methylsulfonyl)-[1,1'-biphenyl]-4-yl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide (DPC423), a highly potent, selective, and orally bioavailable inhibitor of blood coagulation factor XaD J Pinto, M J Orwat, S Wang, et al.
Pageof 12